Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FFR Versus iFR in Assessment of Hemodynamic Lesion Significance Using Gene Polymorphisms and Lesion Morphology Assessed by OCT (FiGARO Trial)

NCT03033810 is registered in ClinicalTrials.gov with General University Hospital, Prague as lead sponsor.

NCT NCT03033810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03033810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FFR Versus iFR in Assessment of Hemodynamic Lesion Significance Using Gene Polymorphisms and Lesion Morphology Assessed by OCT (FiGARO Trial)
Lead sponsor
General University Hospital, Prague
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2019
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary circulation, endothelial cells, hemodynamics, polymorphism, genetic, tomography, optical coherence